Skip to main content
. 2018 Jul 20;18:81. doi: 10.1186/s12874-018-0540-8

Table 1.

NPC test for comparisons between CD and UC patients

Variables Crohn’s disease Ulcerative colitis p-value
Diagnosis age 43.80 ± 21.59 45.87 ± 20.83 0.0281
Gender (M% /F%) 49.3 /50.7 57.7/42.3 0.0019
Smoking habit 43.9 /56.1 35.2 / 64.8 0.0001
Immun. therapy 38.4/61.6 26.4 / 73.6 0.0002
Duration of therapy 12.27 ± 8.67 14.92 ± 9.84 0.0032
Biological drugs (BD) 18.4/81.6 8.7/91.3 0.0004
Duration of BD 12.23 ± 7.33 16.03 ± 9.41 0.0053
Re-hospitalization 45.6 / 54.4 27.8 / 72.2 0.0008
Adverse events 17.9 / 82.1 9.2 / 90.8 0.0007
Infections 7.0/93.0 7.6 / 92.4 0.6274
Cancers 3.6 / 96.4 2.5 / 97.5 0.2755
Diabetes 5.6 / 94.4 10.6/89.4 0.0006
Hypertension 20.3 / 79.7 19.6/80.4 0.7376
Heart failure 5.7 / 94.3 5.7 / 94.3 0.9852
Kidney failure 2.1 /97.9 2.6 / 97.4 0.5074
Pulmonary failure 3.6/96.4 5.1 /94.9 0.1553
Neuropathy 1.7/98.3 1.6/98.4 0.8858
Liver disease 1.6/98.4 1.3 / 98.7 0.6075
Charlson score 1.47 ± 1.81 1.20 ± 1.39 0.0316
Surgery 19.7 /80.3 5.3 / 94.7 0.0003
Final exitus 97.9/2.1 97.6 / 2.4 0.6643
Follow-up time 34.57 ± 4.54 34.92 ± 4.16 0.0577
COMBINED p-value 0.0000

Note: the values in italics identify the significant variables (level α = 0.05)